ClinConnect ClinConnect Logo
Search / Trial NCT06783712

Comparative Study Between Ultrasound-Guided IPACK Block (Interspace Between the Popliteal Artery and the Posterior Capsule of the Knee) with Adductor Canal Block Versus Adductor Canal Block Alone for Postoperative Pain Management in Total Knee Arthroplasty

Launched by AIN SHAMS UNIVERSITY · Jan 15, 2025

Trial Information

Current as of July 01, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is looking at different methods to manage pain after total knee replacement surgery. Specifically, it compares two types of nerve blocks: one involves an injection in the area between the popliteal artery and the back of the knee (called the IPACK block) combined with another block (the adductor canal block), while the other group will only receive the adductor canal block. The goal is to see which method helps reduce pain and allows patients to start moving around more quickly after their surgery.

To participate in this trial, you should be an adult and meet certain health criteria. For example, you need to be able to give your consent and not have serious health issues, such as certain blood disorders or neuromuscular conditions. If you join the study, you will receive one of the two pain management techniques after your surgery, and the researchers will monitor how well it works by asking about your pain levels. This trial is currently recruiting participants, and it aims to improve recovery experiences for patients undergoing knee replacement surgery.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • -
  • Exclusion Criteria:
  • The patient refusal to give written consent.
  • Previously known allergy to one of the drugs being used in the study.
  • Physical status: ASA grades more than III
  • History or evidence of coagulopathy, use of anti-coagulant or anti-platelet therapy.
  • Patients with neuromuscular disorders
  • Injection site infection.

About Ain Shams University

Ain Shams University, established in Cairo, Egypt, is a prestigious higher education institution renowned for its commitment to academic excellence and research innovation. As a clinical trial sponsor, the university leverages its extensive resources and expertise in various medical and scientific disciplines to advance healthcare through rigorous research initiatives. With a focus on ethical practices and adherence to regulatory standards, Ain Shams University aims to contribute to the development of new therapies and improve patient outcomes, fostering collaboration among researchers, healthcare professionals, and industry partners in the pursuit of medical advancements.

Locations

Cairo, , Egypt

Patients applied

0 patients applied

Trial Officials

Hager Talal Mohamed, MBBCH

Principal Investigator

Anesthesia Resident Ain Shams University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported